<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Practice 3, Medical Centre, Bridlington</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where Practice 3, Medical Centre, Bridlington is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1104020G0&amp;denomIds=11.4.2&amp;selectedTab=summary">Flurbiprofen sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Other anti-inflammatory preparations</td>
      <td>69</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>12.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1104020G0BBABAC&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Ocufen 0.03% eye drops 0.4ml unit dose : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0402030R0&amp;denomIds=4.2.3&amp;selectedTab=summary">Asenapine</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Drugs used for mania and hypomania</td>
      <td>108</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>11.58</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0402030R0AAABAB&amp;denomIds=4.2.3&amp;selectedTab=summary" target="_blank">Asenapine 5mg sublingual tablets sugar free : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021M0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefradine</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>19</td>
      <td>Cephalosporins</td>
      <td>37</td>
      <td>0.51</td>
      <td>0.02</td>
      <td>0.08</td>
      <td>6.47</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021M0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefradine 250mg capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021M0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefradine 500mg capsules : 18</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0404000R0&amp;denomIds=4.4&amp;selectedTab=summary">Modafinil</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>CNS Stimulants and drugs used for ADHD</td>
      <td>7</td>
      <td>0.86</td>
      <td>0.06</td>
      <td>0.12</td>
      <td>6.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0404000R0AAACAC&amp;denomIds=4.4&amp;selectedTab=summary" target="_blank">Modafinil 200mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0404000R0AAAAAA&amp;denomIds=4.4&amp;selectedTab=summary" target="_blank">Modafinil 100mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021A0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefaclor</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Cephalosporins</td>
      <td>37</td>
      <td>0.16</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>5.12</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021A0BBAEAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Distaclor MR 375mg tablets : 6</a></div></td></tr></tbody></table>

        <h2>Prescribing where Practice 3, Medical Centre, Bridlington is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefalexin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Cephalosporins</td>
      <td>37</td>
      <td>0.32</td>
      <td>0.96</td>
      <td>0.10</td>
      <td>-6.22</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0AAAHAH&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg capsules : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0501021L0AAAGAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0404000M0&amp;denomIds=4.4&amp;selectedTab=summary">Methylphenidate hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>CNS Stimulants and drugs used for ADHD</td>
      <td>7</td>
      <td>0.00</td>
      <td>0.65</td>
      <td>0.21</td>
      <td>-3.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1310040Q0&amp;denomIds=13.10.4&amp;selectedTab=summary">Permethrin</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Parasiticidal preparations</td>
      <td>19</td>
      <td>0.11</td>
      <td>0.84</td>
      <td>0.25</td>
      <td>-2.91</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1310040Q0AAABAB&amp;denomIds=13.10.4&amp;selectedTab=summary" target="_blank">Permethrin 5% cream : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1306010Y0&amp;denomIds=13.6.1&amp;selectedTab=summary">Benzoyl peroxide and clindamycin phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Topical preparations for acne</td>
      <td>84</td>
      <td>0.01</td>
      <td>0.38</td>
      <td>0.14</td>
      <td>-2.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=1306010Y0AAAAAA&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Benzoyl peroxide 5% / Clindamycin 1% gel : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2539</td>
      <td>Selective beta(2)-agonists</td>
      <td>3153</td>
      <td>0.81</td>
      <td>0.91</td>
      <td>0.05</td>
      <td>-2.21</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 2168</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 66</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 202</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 39</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BIAFAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose inhaler CFC free (Teva) : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BMABBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose Autohaler : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0AAAQAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 200micrograms/dose dry powder inhaler : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BEANAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 2.5mg Nebules : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B81069&amp;numIds=0301011R0BMAAAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose inhaler : 6</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>